Placebo-only-controlled versus active-controlled trials of new drugs for nine common life-threatening diseases
Open Access Journal of Clinical Trials · 2018
DOI: 10.2147/oajct.s156054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access Journal of Clinical Trials, 2018. Verfasst von Sarah Sorscher und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sorscher, S., AbuDagga, A., Almashat, S., Carome, M., & Wolfe, S. (2018). Placebo-only-controlled versus active-controlled trials of new drugs for nine common life-threatening diseases. Open Access Journal of Clinical Trials. https://doi.org/10.2147/oajct.s156054
Vancouver
Sorscher S, AbuDagga A, Almashat S, Carome M, Wolfe S. Placebo-only-controlled versus active-controlled trials of new drugs for nine common life-threatening diseases. Open Access Journal of Clinical Trials. 2018. doi:10.2147/oajct.s156054
BibTeX
@article{Sorscher2018,
author = {Sorscher, Sarah and AbuDagga, Azza and Almashat, Sammy and Carome, Michael and Wolfe, Sidney},
title = {Placebo-only-controlled versus active-controlled trials of new drugs for nine common life-threatening diseases},
journal = {Open Access Journal of Clinical Trials},
year = {2018},
doi = {10.2147/oajct.s156054}
}
EUVIMED